Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decrease in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant decrease in short interest in December. As of December 15th, there was short interest totaling 41,927 shares, a decrease of 19.0% from the November 30th total of 51,761 shares. Based on an average daily volume of 11,248 shares, the short-interest ratio is presently 3.7 days. Approximately 3.3% of the company’s shares are sold short. Approximately 3.3% of the company’s shares are sold short. Based on an average daily volume of 11,248 shares, the short-interest ratio is presently 3.7 days.

Arcadia Biosciences Price Performance

Shares of RKDA traded up $0.16 during mid-day trading on Wednesday, reaching $1.98. The company’s stock had a trading volume of 51,943 shares, compared to its average volume of 144,243. Arcadia Biosciences has a 12-month low of $1.76 and a 12-month high of $6.71. The stock has a market cap of $2.71 million, a PE ratio of 0.78 and a beta of 0.48. The company’s 50 day moving average is $3.59 and its 200 day moving average is $3.95.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.54) by $1.16. Arcadia Biosciences had a negative return on equity of 8.80% and a negative net margin of 97.97%.The firm had revenue of $1.30 million during the quarter, compared to the consensus estimate of $1.90 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.